Related Articles
MicroRNA‑301a‑3p promotes triple‑negative breast cancer progression through downregulating MEOX2
Loss of miR‑873 contributes to gemcitabine resistance in triple‑negative breast cancer via targeting ZEB1
miR-187 inhibits the growth of cervical cancer cells by targeting FGF9 Retraction in /10.3892/or.2023.8632
Overexpression of microRNA‑620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD
miR‑205‑5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation